Advertisement

Organisation › Details
Odyssey Therapeutics Inc.
Odyssey Therapeutics is a biotechnology company focused on discovering, developing and commercializing the next generation of immunomodulators and oncology medicines. Composed of an expert team of drug hunters, scientists and industry leaders in foundational biology, chemistry and data sciences, Odyssey is transforming drug discovery to accelerate and drive the creation and efficient delivery of life-enhancing precision medicines to patients. *
![]() |
Start | 2021-12-07 existent |
Group | Odyssey Therapeutics (Group) | |
![]() |
Industry | immuno modulatory compound (IMO) |
Industry 2 | cancer drug | |
![]() |
Person | Glick, Gary D. (Odyssey Therapeutics 202112 CEO + Co-Founder before Scorpion Therapeutics + IFM Therapeutics) |
Person 2 | Gordon, Carl L. (OrbiMed Advisors 201509 Partner) | |
![]() |
Region | Boston, MA |
Country | United States (USA) | |
Street | 51 Sleeper Street | |
City | 02210 Boston, MA | |
Tel | +1-617-865-9628 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Odyssey Therapeutics, Inc.. (12/5/23). "Press Release: Odyssey Therapeutics Announces $101 Million Series C Financing". Boston, MA. | ||
Record changed: 2023-12-08 |
Advertisement

More documents for Odyssey Therapeutics (Group)
- [1] Odyssey Therapeutics, Inc.. (12/5/23). "Press Release: Odyssey Therapeutics Announces $101 Million Series C Financing". Boston, MA....
- [2] Odyssey Therapeutics, Inc.. (12/7/21). "Press Release: Odyssey Therapeutics Announces $218 Million Series A Financing to Advance Next Generation Inflammation and Oncology Medicines". Boston, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top